Michael T Mullen Selected Research

Cerebral Infarction

11/2006

Safety and efficacy of thrombolytic therapy in postoperative cerebral infarctions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael T Mullen Research Topics

Disease

17	Stroke (Strokes) 06/2022 - 11/2006
11	Ischemic Stroke 01/2021 - 11/2006
4	Hemorrhage 01/2021 - 11/2006
4	Cerebral Hemorrhage 08/2018 - 09/2012
2	Brain Injuries (Brain Injury) 08/2018 - 01/2018
1	Fever (Fevers) 06/2022
1	Renal Insufficiency (Renal Failure) 06/2022
1	Hemolytic Anemia 06/2022
1	Thrombocytopenia (Thrombopenia) 06/2022
1	Thrombotic Thrombocytopenic Purpura 06/2022
1	Edema (Dropsy) 01/2021
1	Hydrocephalus (Hydrocephaly) 01/2021
1	Retinal Artery Occlusion 01/2020
1	Atrophy 01/2020
1	Pathologic Constriction (Stenosis) 02/2018
1	Atrial Fibrillation 01/2018
1	Seizures (Absence Seizure) 08/2013
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 09/2012
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2012
1	Thrombosis (Thrombus) 01/2012
1	Spinal Cord Ischemia 01/2007
1	Cerebral Infarction 11/2006

Drug/Important Bio-Agent (IBA)

7	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2018 - 09/2012
1	thiamine triphosphorate (TTP)IBA 06/2022
1	Metalloproteases (Metalloproteinases)IBA 06/2022
1	DisintegrinsIBA 06/2022
1	Hemoglobins (Hemoglobin)IBA 06/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021
1	EnzymesIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	LigandsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	ChemokinesIBA 01/2021
1	AnticoagulantsIBA 10/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	SteroidsIBA 01/2020
1	Saline SolutionIBA 11/2019
1	Immunologic Factors (Immunomodulators)IBA 08/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2016
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2015
1	Dabigatran FDA Link 11/2013
1	ConvulsantsIBA 08/2013
1	Antiphospholipid AntibodiesIBA 01/2012
1	AntibodiesIBA 01/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	CationsIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 03/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2006

Therapy/Procedure

8	Therapeutics 06/2022 - 01/2007
3	Thrombectomy 01/2021 - 10/2018
3	Thrombolytic Therapy 11/2016 - 11/2006
1	Carotid Endarterectomy 02/2018
1	Catheter Ablation 01/2018
1	Enteral Nutrition (Feeding, Tube) 09/2014
1	Time-to-Treatment 09/2012
1	Endovascular Aneurysm Repair 01/2007
1	Embolectomy 11/2006
1	Mechanical Thrombolysis 11/2006
1	Operative Surgical Procedures 11/2006
1	Craniotomy 11/2006